Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adults

Alzheimer's Research and Therapy

Volumn 9, Issue 1, 2017, Pages

  Li, Ge ^a,b   Shofer, Jane B ^b   Petrie, Eric C ^a,b   Yu, Chang En ^a   Wilkinson, Charles W ^a,b   Figlewicz, Dianne P ^a,b   Shutes David, Andrew ^a   Zhang, Jing ^b   Montine, Thomas J ^c   Raskind, Murray A ^a,b   Quinn, Joseph F ^d,e   Galasko, Douglas R ^f   Peskind, Elaine R ^a,b  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d PORTLAND VA MEDICAL CENTER   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Age; Alzheimer's disease; APOE genotype; Biomarkers; Cerebrospinal fluid; Cerebrovascular disease; Gender

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; TAU 181 PROTEIN; TAU PROTEIN; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); APOLIPOPROTEIN E4; BIOLOGICAL MARKER; PEPTIDE FRAGMENT;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENETIC RISK; GENOTYPE; HUMAN; INFORMED CONSENT; LONGITUDINAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN PHOSPHORYLATION; SEX DIFFERENCE; AGING; CEREBROSPINAL FLUID; GENETICS; METABOLISM; MIDDLE AGED; SEXUAL CHARACTERISTICS; VASCULAR DISEASE; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; APOLIPOPROTEIN E4; BIOMARKERS; E-SELECTIN; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; SEX CHARACTERISTICS; TAU PROTEINS; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR DISEASES; YOUNG ADULT;

EID: 85021628789     PISSN: None     EISSN: 17589193     Source Type: Journal    
DOI: 10.1186/s13195-017-0271-9     Document Type: Article

References (40)

1. Andersen K, Launer LJ, Dewey ME, Letenneur L, Ott A, Copeland JR, Dartigues JF, Kragh-Sorensen P, Baldereschi M, Brayne C, et al. Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurol. 1999;53:1992-7.
2. Miech RA, Breitner JC, Zandi PP, Khachaturian AS, Anthony JC, Mayer L. Incidence of AD may decline in the early 90s for men, later for women: The Cache County study. Neurology. 2002;58:209-18.
3. Kukull WA, Higdon R, Bowen JD, McCormick WC, Teri L, Schellenberg GD, van Belle G, Jolley L, Larson EB. Dementia and Alzheimer disease incidence: A prospective cohort study. Arch Neurol. 2002;59:1737-46.
4. Chene G, Beiser A, Au R, Preis SR, Wolf PA, Dufouil C, Seshadri S. Gender and incidence of dementia in the Framingham Heart Study from mid-Adult life. Alzheimers Dement. 2015;11:310-20.
5. Henderson VW. Estrogen, cognition, and a woman's risk of Alzheimer's disease. Am J Med. 1997;103:11S-8S.
6. Zandi PP, Carlson MC, Plassman BL, Welsh-Bohmer KA, Mayer LS, Steffens DC, Breitner JC. Hormone replacement therapy and incidence of Alzheimer disease in older women: The Cache County Study. JAMA. 2002;288:2123-9.
7. Li G, Sokal I, Quinn JF, Leverenz JB, Brodey M, Schellenberg GD, Kaye JA, Raskind MA, Zhang J, Peskind ER, Montine TJ. CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: A follow-up study. Neurology. 2007;69:631-9.
8. Fagan AM, Roe CM, Xiong C, Mintun MA, Morris JC, Holtzman DM. Cerebrospinal fluid tau/beta-Amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults. Arch Neurol. 2007;64:343-9.
9. Fagan AM, Mintun MA, Mach RH, Lee SY, Dence CS, Shah AR, LaRossa GN, Spinner ML, Klunk WE, Mathis CA, et al. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. Ann Neurol. 2006;59:512-9.
10. Fleisher AS, Chen K, Quiroz YT, Jakimovich LJ, Gutierrez Gomez M, Langois CM, Langbaum JB, Roontiva A, Thiyyagura P, Lee W, et al. Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: A cross-sectional study. JAMA Neurol. 2015;72:316-24.
11. Li G, Xiong K, Korff A, Pan C, Quinn J, Galasko D, Liu C, Montine TJ, Peskind E, Zhang J. Increased CSF E-selectin in clinical Alzheimer's disease without altered CSF Abeta 42 and Tau. J Alzheimers Dis. 2015;47:883-7 in press.
12. Ewers M, Mielke MM, Hampel H. Blood-based biomarkers of microvascular pathology in Alzheimer's disease. Exp Gerontol. 2010;45:75-9.
13. Kawamura T, Umemura T, Kanai A, Nagashima M, Nakamura N, Uno T, Nakayama M, Sano T, Hamada Y, Nakamura J, Hotta N. Soluble adhesion molecules and C-reactive protein in the progression of silent cerebral infarction in patients with type 2 diabetes mellitus. Metabolism. 2006;55:461-6.
14. Kawamura T, Umemura T, Kanai A, Uno T, Matsumae H, Sano T, Sakamoto N, Sakakibara T, Nakamura J, Hotta N. The incidence and characteristics of silent cerebral infarction in elderly diabetic patients: Association with serum-soluble adhesion molecules. Diabetologia. 1998;41:911-7.
15. Li G, Millard SP, Peskind ER, Zhang J, Yu CE, Leverenz JB, Mayer C, Shofer JS, Raskind MA, Quinn JF, et al. Cross-sectional and longitudinal relationships between cerebrospinal fluid biomarkers and cognitive function in people without cognitive impairment from across the adult life span. JAMA Neurol. 2014;71:742-51.
16. Peskind ER, Riekse R, Quinn JF, Kaye J, Clark CM, Farlow MR, Decarli C, Chabal C, Vavrek D, Raskind MA, Galasko D. Safety and acceptability of the research lumbar puncture. Alzheimer Dis Assoc Disord. 2005;19:220-5.
17. Mattsson N, Andreasson U, Persson S, Arai H, Batish SD, Bernardini S, Bocchio-Chiavetto L, Blankenstein MA, Carrillo MC, Chalbot S, et al. The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers. Alzheimers Dement. 2011;7:386-95. e386.
18. Pan C, Korff A, Galasko D, Ginghina C, Peskind E, Li G, Quinn J, Montine TJ, Cain K, Shi M, Zhang J. Diagnostic values of cerebrospinal fluid T-Tau and Abeta42 using meso scale discovery assays for Alzheimer's disease. J Alzheimers Dis. 2015;45:709-19.
19. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 1990;31:545-8.
20. Harrell FEJ. Regression modeling stratigies with applications to linear models, logistic regression and survival analysis. New York: Springer; 2001.
21. Davison AC, Hinkley DV. Bootstrap methods and their applications. Cambridge: Cambridge University Press; 1997.
22. Team RC. R: A language and environment for statistical computing. R Foundation for Statistical Computing: Vienna; 2012.
23. Harrell Jr F. rms: Regression modeling strategies. In R package, 36-0 edition. R Foundation for Statistical Computing: Vienna; 2012.
24. Canty A, Ripley B. boot: Bootstrap R (S-Plus) functions. In R package, 13-13 edition. R Foundation for Statistical Computing: Vienna; 2014.
25. Vlassenko AG, McCue L, Jasielec MS, Su Y, Gordon BA, Xiong C, Holtzman DM, Benzinger TL, Morris JC, Fagan AM. Imaging and cerebrospinal fluid biomarkers in early preclinical alzheimer disease. Ann Neurol. 2016;80:379-87.
26. Peskind ER, Li G, Shofer J, Quinn JF, Kaye JA, Clark CM, Farlow MR, DeCarli C, Raskind MA, Schellenberg GD, et al. Age and apolipoprotein E4 allele effects on cerebrospinal fluid beta-Amyloid 42 in adults with normal cognition. Arch Neurol. 2006;63:936-9.
27. Sutphen CL, Jasielec MS, Shah AR, Macy EM, Xiong C, Vlassenko AG, Benzinger TL, Stoops EE, Vanderstichele HM, Brix B, et al. Longitudinal cerebrospinal fluid biomarker changes in preclinical Alzheimer disease during middle age. JAMA Neurol. 2015;72(9):1029-42.
28. Jack Jr CR, Wiste HJ, Weigand SD, Knopman DS, Vemuri P, Mielke MM, Lowe V, Senjem ML, Gunter JL, Machulda MM, et al. Age, sex, and APOE epsilon4 effects on memory, brain structure, and beta-Amyloid across the adult life span. JAMA Neurol. 2015;72:511-9.
29. Resnick SM, Bilgel M, Moghekar A, An Y, Cai Q, Wang MC, Thambisetty M, Prince JL, Zhou Y, Soldan A, et al. Changes in Abeta biomarkers and associations with APOE genotype in 2 longitudinal cohorts. Neurobiol Aging. 2015;36:2333-9.
30. Zhao Q, Lu J, Yao Z, Wang S, Zhu L, Wang J, Chen B. Upregulation of Abeta42 in the brain and bodily fluids of rhesus monkeys with aging. J Mol Neurosci. 2017;61:79-87.
31. Kauwe JS, Jacquart S, Chakraverty S, Wang J, Mayo K, Fagan AM, Holtzman DM, Morris JC, Goate AM. Extreme cerebrospinal fluid amyloid beta levels identify family with late-onset Alzheimer's disease presenilin 1 mutation. Ann Neurol. 2007;61:446-53.
32. Altmann A, Tian L, Henderson VW, Greicius MD. Alzheimer's Disease Neuroimaging Initiative I: sex modifies the APOE-related risk of developing Alzheimer disease. Ann Neurol. 2014;75:563-73.
33. Sampedro F, Vilaplana E, de Leon MJ, Alcolea D, Pegueroles J, Montal V, Carmona-Iragui M, Sala I, Sanchez-Saudinos MB, Anton-Aguirre S, et al. APOE-by-sex interactions on brain structure and metabolism in healthy elderly controls. Oncotarget. 2015;6:26663-74.
34. Sonnen JA, Larson EB, Haneuse S, Woltjer R, Li G, Crane PK, Craft S, Montine TJ. Neuropathology in the adult changes in thought study: A review. J Alzheimers Dis. 2009;18:703-11.
35. White L, Petrovitch H, Hardman J, Nelson J, Davis DG, Ross GW, Masaki K, Launer L, Markesbery WR. Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann N Y Acad Sci. 2002;977:9-23.
36. Wang LY, Larson EB, Sonnen JA, Shofer JB, McCormick W, Bowen JD, Montine TJ, Li G. Blood pressure and brain injury in older adults: findings from a community-based autopsy study. J Am Geriatr Soc. 2009;57:1975-81.
37. Sonnen JA, Larson EB, Brickell K, Crane PK, Woltjer R, Montine TJ, Craft S. Different patterns of cerebral injury in dementia with or without diabetes. Arch Neurol. 2009;66:315-22.
38. Wildman RP, Kaplan R, Manson JE, Rajkovic A, Connelly SA, Mackey RH, Tinker LF, Curb JD, Eaton CB, Wassertheil-Smoller S. Body size phenotypes and inflammation in the Women's Health Initiative Observational Study. Obesity (Silver Spring). 2011;19:1482-91.
39. Huang Z, Yin Q, Sun W, Zhu W, Li Y, Liu W, Xiao L, Duan Z, Cai Q, Liu D, et al. Microbleeds in ischemic stroke are associated with lower serum adiponectin and higher soluble E-selectin levels. J Neurol Sci. 2013;334:83-7.
40. Koran ME, Wagener M, Hohman TJ, Alzheimer's NI. Sex differences in the association between AD biomarkers and cognitive decline. Brain Imaging Behav. 2016;11(1):205-13.